Fara Brasó‐Maristany

Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer

Francesco Schettini, Núria Chic, Fara Brasó‐Maristany et al. · npj Breast Cancer · 2021 · 691 citations · Full text

Medicine, Cancer Biology, Oncology +10

Frequency and spectrum of PIK3CA somatic mutations in breast cancer

Olga Martínez‐Sáez, Núria Chic, Tomás Pascual et al. · Breast Cancer Research · 2020 · 376 citations · Full text

Medicine, Molecular Medicine, Oncology +17

PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancer

Fara Brasó‐Maristany, Simone Filosto, Steven Catchpole et al. · Nature Medicine · 2016 · 245 citations · Full text

Medicine, Cancer Biology, Oncology +17

HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade

Aleix Prat, Tomás Pascual, Carmine De Angelis et al. · JNCI Journal of the National Cancer Institute · 2019 · 169 citations · Full text

Medicine, Oncology, Pharmacology +17

Correlative Biomarker Analysis of Intrinsic Subtypes and Efficacy Across the MONALEESA Phase III Studies

Anwesha Chaudhury, Nadia Solovieff, Laia Paré et al. · Journal of Clinical Oncology · 2021 · 153 citations · Full text

Medicine, Oncology, Pharmacology +17